Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP396725.RAT3S7iDJl0PqdQjW-gZ96MEm03ijzoSAywX1WivLrz8c130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396725.RAT3S7iDJl0PqdQjW-gZ96MEm03ijzoSAywX1WivLrz8c130_provenance.
• NP396856.RARPRj48QW6by_ZU_9Ho9VHXS65EIjKf4cTJdHCeFe1Tk130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396856.RARPRj48QW6by_ZU_9Ho9VHXS65EIjKf4cTJdHCeFe1Tk130_provenance.
• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP941909.RA8RVCg3qQtE2DN39BOF5Mm_GWkun907kM2LgqPZV6EHE130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941909.RA8RVCg3qQtE2DN39BOF5Mm_GWkun907kM2LgqPZV6EHE130_provenance.
• NP941911.RAz7fFwyRLwyfBA-gd98T4W70jfM7gbSJUvkJs2x-P1eU130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941911.RAz7fFwyRLwyfBA-gd98T4W70jfM7gbSJUvkJs2x-P1eU130_provenance.
• NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941912.RA4LAAQr9fJsKDa--aMXFKvTGKYD-JUPzB7yrl85lPIrw130_provenance.
• NP941904.RAa0aH98nQHStCjzFjcFzACknUsrRwRYF1jqK83gK2n64130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941904.RAa0aH98nQHStCjzFjcFzACknUsrRwRYF1jqK83gK2n64130_provenance.
• NP397033.RAG1qmK8znp5_W1HeGDAe0_QDuOIMU4L4XdbX152NZdXM130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397033.RAG1qmK8znp5_W1HeGDAe0_QDuOIMU4L4XdbX152NZdXM130_provenance.
• NP397294.RArT6vGQHcR7PLENEmGMfzCFZ-Uxw24E5Qtrk3Yg01C1c130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397294.RArT6vGQHcR7PLENEmGMfzCFZ-Uxw24E5Qtrk3Yg01C1c130_provenance.
• NP941906.RAhwSYYrg9-zJZGZ-7VRzaReYmlXWEA8jl6qc-qDfyHNE130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941906.RAhwSYYrg9-zJZGZ-7VRzaReYmlXWEA8jl6qc-qDfyHNE130_provenance.
• NP941910.RAvu4iAGxJwZ6u8PQf3SP06VPuQVMJ68PFlTKEiAeDg0o130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941910.RAvu4iAGxJwZ6u8PQf3SP06VPuQVMJ68PFlTKEiAeDg0o130_provenance.
• NP941907.RAN6Jm7X5IBLZv95FLKM_aU05dCaqoIMTAM5K1HFc00kY130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941907.RAN6Jm7X5IBLZv95FLKM_aU05dCaqoIMTAM5K1HFc00kY130_provenance.
• NP941908.RAIToRk_t7Yg7p7mjv8uHeRSBbkQu7xdZtparXeSR-Qr4130_assertion description "[We analyzed the influence of 8 germinal polymorphisms of candidate genes potentially related to EGFR signalling (EGFR, EGF, CCND1) or antibody-directed cell cytotoxicity (FCGR2A and FCGR3A) on outcome of colorectal cancer (CRC) patients receiving cetuximab-based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941908.RAIToRk_t7Yg7p7mjv8uHeRSBbkQu7xdZtparXeSR-Qr4130_provenance.